Etoposide with lonidamine or pentoxifylline as modulators of alkylating agent activity in vivo
暂无分享,去创建一个
B. Teicher | T. Herman | B. Dezube | E. Frei | S. Holden | E. Frei | J. Tanaka | Bruce Dezube
[1] B. Teicher,et al. Trimodality therapy (drug/hyperthermia/radiation) with BCNU or mitomycin C. , 1990, International journal of radiation oncology, biology, physics.
[2] B. Teicher,et al. Interaction of hyperthermia and radiation in murine cells: hypoxia and acidosis in vitro, tumor subpopulations in vivo. , 1989, Cancer research.
[3] B. Teicher,et al. Combined modality therapy with bleomycin, hyperthermia, and radiation. , 1988, Cancer research.
[4] A Ward,et al. Pentoxifylline , 1987, Drugs.
[5] J. Wang. Recent studies of DNA topoisomerases. , 1987, Biochimica et biophysica acta.
[6] B. Silvestrini,et al. Cell membrane changes induced by lonidamine in human erythrocytes and T lymphocytes, and Ehrlich ascites tumor cells. , 1987, Experimental and molecular pathology.
[7] B. Teicher,et al. Approaches to defining the mechanism of enhancement by Fluosol-DA 20% with carbogen of melphalan antitumor activity. , 1987, Cancer research.
[8] D. Chaplin,et al. Intermittent blood flow in a murine tumor: radiobiological effects. , 1987, Cancer research.
[9] P. Keng,et al. Cell cycle specific toxicity of the Hoechst 33342 stain in untreated or irradiated murine tumor cells. , 1986, Cancer research.
[10] R. Chalkley,et al. Novobiocin precipitates histones at concentrations normally used to inhibit eukaryotic type II topoisomerase. , 1986, Nucleic acids research.
[11] W. Ross,et al. Cross-resistance to intercalating agents in an epipodophyllotoxin-resistant Chinese hamster ovary cell line: evidence for a common intracellular target. , 1986, Cancer research.
[12] A. Floridi,et al. Kinetics of inhibition of mitochondrial respiration by antineoplastic agent lonidamine , 1986 .
[13] P. Giunti,et al. Haemorrheological improvement by pentoxifylline in patients with peripheral arterial occlusive disease. , 1986, Current medical research and opinion.
[14] W. Ross. DNA topoisomerases as targets for cancer therapy. , 1985, Biochemical pharmacology.
[15] E. Frei. Curative cancer chemotherapy. , 1985, Cancer research.
[16] D. Chaplin,et al. Pharmacokinetics, binding and distribution of Hoechst 33342 in spheroids and murine tumours. , 1985, British Journal of Cancer.
[17] M. Boddi,et al. Pentoxifylline Treatment in Patients with Occlusive Peripheral Arterial Disease. Circulatory Changes and Effects on Prostaglandin Synthesis , 1985, Angiology.
[18] D. Botstein,et al. DNA topoisomerase II is required at the time of mitosis in yeast , 1985, Cell.
[19] D. Chaplin,et al. Cell selection from a murine tumour using the fluorescent probe Hoechst 33342. , 1985, British Journal of Cancer.
[20] D. Aviado,et al. Pentoxifylline: A New Drug for the Treatment of Intermittent Claudication; Mechanism of Action, Pharmacokinetics, Clinical Efficacy and Adverse Effects , 1984, Pharmacotherapy.
[21] A. Worcel,et al. Chromatin assembly in Xenopus oocytes: In vitro studies , 1984, Cell.
[22] B. Teicher,et al. Perfluorochemical emulsions can increase tumor radiosensitivity. , 1984, Science.
[23] A. Floridi,et al. Effects of Lonidamine on murine and human tumor cells in vitro. A morphological and biochemical study. , 1984, Oncology.
[24] A. Lehninger,et al. Action of the antitumor and antispermatogenic agent lonidamine on electron transport in Ehrlich ascites tumor mitochondria. , 1983, Archives of biochemistry and biophysics.
[25] A. Pardee,et al. Inhibitor evidence for allosteric interaction in the replitase multienzyme complex , 1983, Nature.
[26] P. Karran,et al. Inducible DNA repair enzymes involved in the adaptive response to alkylating agents. , 1982, Biochimie.
[27] L. Thompson,et al. Defective removal of DNA cross-links in a repair-deficient mutant of Chinese hamster cells. , 1982, Cancer research.
[28] T. Lindahl,et al. A common mechanism for repair of O6-methylguanine and O6-ethylguanine in DNA. , 1982, Journal of molecular biology.
[29] B. Silvestrini,et al. Effect of lonidamine on the energy metabolism of Ehrlich ascites tumor cells. , 1981, Cancer research.
[30] D. Scudiero,et al. Dependence of mammalian DNA synthesis on DNA supercoiling. III. Characterization of the inhibition of replicative and repair-type DNA synthesis by novobiocin and nalidixic acid. , 1981, Biochimica et biophysica acta.
[31] B. Silvestrini,et al. Lonidamine, a selective inhibitor of aerobic glycolysis of murine tumor cells. , 1981, Journal of the National Cancer Institute.
[32] M. Colvin,et al. Transport of melphalan by sensitive and resistant L1210 cells. , 1980, Cancer research.
[33] G. Goldenberg,et al. Membrane transport of alkylating agents. , 1980, Pharmacology & therapeutics.
[34] Ehrly Am. The effect of pentoxifylline on the deformability of erythrocytes and on the muscular oxygen pressure in patients with chronic arterial disease. , 1979 .
[35] K. Kohn,et al. DNA cross-linking by in vivo treatment with 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea of sensitive and resistant human colon carcinoma xenograms in nude mice. , 1978, Cancer research.
[36] A. Ehrly. The effect of pentoxifylline on the flow properties of human blood. , 1978, Current medical research and opinion.
[37] M. Rabinovitz,et al. Amino acid-conferred protection against melphalan--characterization of melphalan transport and correlation of uptake with cytotoxicity in cultured L1210 murine leukemia cells. , 1978, Biochemical pharmacology.
[38] G. Goldenberg,et al. Evidence for a transport carrier of nitrogen mustard in nitrogen mustard-sensitive and -resistant L5178Y lymphoblasts. , 1970, Cancer research.